Try our Advanced Search for more refined results
May 27, 2021
Ziegler v. GW Pharmaceuticals, PLC et al
Case Number:
3:21-cv-01019
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 21, 2023
GW Pharma Investors Ink $7.75M Deal In Suit Over Jazz Sale
GW Pharmaceuticals investors urged a California federal judge on Monday to grant preliminary approval to a $7.75 million settlement that ends their claims the British company misled shareholders to push through its $7.2 billion sale to Ireland-based Jazz Pharmaceuticals, calling it an "excellent" result.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login